NCT01375569: TRC105 for Liver Cancer That Has Not Responded to Sorafenib |
|
|
| Completed | 2 | 11 | US | TRC105 | National Cancer Institute (NCI) | Hepatocellular Carcinoma, Hepatocellular Cancer, Carcinoma, Hepatocellular | 02/14 | 12/15 | | |
| Completed | 1/2 | 27 | US | TRC 105, Sorafenib, Nexavar | National Cancer Institute (NCI) | Hepatoma, Liver Neoplasms, Adenoma, Liver Cell, Carcinoma, Hepatocellular, Liver Neoplasms, Experimental | 06/16 | 06/17 | | |